The groundbreaking therapy of this peptide represents a exciting breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide230751.blogzet.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57129201